ZYPREXA RYFONT Trademark

Trademark Overview

On Monday, December 12, 2005, a trademark application was filed for ZYPREXA RYFONT with the United States Patent and Trademark Office. The USPTO has given the ZYPREXA RYFONT trademark a serial number of 78771507. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 9, 2009. This trademark is owned by Eli Lilly and Company. The ZYPREXA RYFONT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders, neurological disorders
zyprexa ryfont

General Information

Serial Number78771507
Word MarkZYPREXA RYFONT
Filing DateMonday, December 12, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 9, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders, neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 16, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, November 9, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 9, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 7, 2009EXTENSION 5 GRANTED
Monday, April 6, 2009EXTENSION 5 FILED
Monday, April 6, 2009TEAS EXTENSION RECEIVED
Saturday, September 27, 2008EXTENSION 4 GRANTED
Thursday, September 25, 2008EXTENSION 4 FILED
Saturday, September 27, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 25, 2008TEAS EXTENSION RECEIVED
Wednesday, April 16, 2008EXTENSION 3 GRANTED
Wednesday, April 2, 2008EXTENSION 3 FILED
Wednesday, April 2, 2008TEAS EXTENSION RECEIVED
Wednesday, October 10, 2007EXTENSION 2 GRANTED
Thursday, September 27, 2007EXTENSION 2 FILED
Thursday, September 27, 2007TEAS EXTENSION RECEIVED
Thursday, June 7, 2007EXTENSION 1 GRANTED
Wednesday, March 7, 2007EXTENSION 1 FILED
Wednesday, March 7, 2007TEAS EXTENSION RECEIVED
Tuesday, October 10, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2006PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2006NOTICE OF PUBLICATION
Friday, May 26, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 19, 2006ASSIGNED TO LIE
Friday, May 12, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 11, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, May 11, 2006EXAMINERS AMENDMENT E-MAILED
Thursday, May 11, 2006EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 9, 2006ASSIGNED TO EXAMINER
Friday, December 16, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

ryfont zyprexa disorders pharmaceutical preparations diseases neurological system central namely treatment prevention